Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Teleflex Inc (TFX)

Teleflex Inc (TFX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Teleflex to Present at the 36th Annual Piper Sandler Healthcare Conference

TFX : 190.64 (+1.71%)
Teleflex to Present at the Jefferies London Healthcare Conference

TFX : 190.64 (+1.71%)
Teleflex Announces Quarterly Dividend

TFX : 190.64 (+1.71%)
Teleflex: Q3 Earnings Snapshot

Teleflex: Q3 Earnings Snapshot

TFX : 190.64 (+1.71%)
Teleflex Reports Third Quarter Financial Results and Full Year 2024 Outlook

TFX : 190.64 (+1.71%)
First Patient Enrolled in Teleflex’s Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT)

TFX : 190.64 (+1.71%)
Teleflex launches next-generation Arrow™ VPS Rhythm™ DLX Device and NaviCurve™ Stylet in Canada

TFX : 190.64 (+1.71%)
Earnings Preview: What to Expect From Teleflex's Report

Teleflex is set to report its third-quarter earnings by the end of this month, with analysts projecting a slight decline in its bottom line.

XLV : 144.03 (+0.80%)
$SPX : 5,948.71 (+0.53%)
TFX : 190.64 (+1.71%)
New Data Presented at ASTRO 2024 Further Demonstrate the Safety and Efficacy of Barrigelâ„¢ Rectal Spacer, the First and Only Sculptable Hyaluronic Acid Rectal Spacer, in Patients Undergoing Radiation Therapy for Prostate Cancer(1-3)

TFX : 190.64 (+1.71%)
Teleflex Announces Third Quarter 2024 Earnings Conference Call Information

TFX : 190.64 (+1.71%)

Barchart Exclusives

Up 882% YTD, Is It Too Late to Buy This Fintech Stock?
A recent guidance boost from DAVE propelled the stock even higher. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar